[go: up one dir, main page]

PE20140580A1 - Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas - Google Patents

Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas

Info

Publication number
PE20140580A1
PE20140580A1 PE2013002557A PE2013002557A PE20140580A1 PE 20140580 A1 PE20140580 A1 PE 20140580A1 PE 2013002557 A PE2013002557 A PE 2013002557A PE 2013002557 A PE2013002557 A PE 2013002557A PE 20140580 A1 PE20140580 A1 PE 20140580A1
Authority
PE
Peru
Prior art keywords
compound
formula
iodophenyl
difluoro
dihydroxy
Prior art date
Application number
PE2013002557A
Other languages
English (en)
Inventor
Peter Fey
Agathe Christine Mayer
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46172787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140580(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PE20140580A1 publication Critical patent/PE20140580A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/71—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78—Halides of sulfonic acids
    • C07C309/79—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms
    • C07C309/82—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms of a carbon skeleton substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/28—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SE REFIERE A UN METODO PARA PREPARAR EL COMPUESTO (S)-N-{3,4-DIFLUORO-2-[(2-FLUORO-4-YODOFENIL)AMINO]-6-METOXIFENIL}-1-[2,3-DIHIDROXI-PROPIL]CICLOPROPANOSULFONAMIDA DE FORMULA (S)-14, EL CUAL COMPRENDE: A) HACER REACCIONAR EL COMPUESTO DE FORMULA (S)-10 CON EL COMPUESTO DE FORMULA (12) EN PRESENCIA DE i) UN BROMURO DE TETRA-N-BUTILAMONIO O BROMURO DE LITIO, ii) UNA BASE TAL COMO PIRIDINA, Y iii) UN DISOLVENTE TAL COMO SULFOLANO, PARA PROPORCIONAR EL COMPUESTO DE FORMULA (S)-13; Y B) AGREGAR UN ACIDO MINERAL ACUOSO TAL COMO ACIDO CLORHIDRICO AL COMPUESTO (S)-13 PARA OBTENER EL COMPUESTO DE FORMULA (S)-14. DICHO COMPUESTO (S)-14 ES UN INHIBIDOR DE MEK1/2 UTIL EN EL TRATAMIENTO DE CANCER
PE2013002557A 2011-05-27 2012-05-24 Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas PE20140580A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11167806 2011-05-27

Publications (1)

Publication Number Publication Date
PE20140580A1 true PE20140580A1 (es) 2014-06-01

Family

ID=46172787

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002557A PE20140580A1 (es) 2011-05-27 2012-05-24 Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas

Country Status (31)

Country Link
US (1) US9328066B2 (es)
EP (1) EP2714652B8 (es)
JP (1) JP5965993B2 (es)
KR (1) KR101939682B1 (es)
CN (1) CN103596921B (es)
AP (1) AP2013007257A0 (es)
AR (1) AR086553A1 (es)
AU (1) AU2012264884B2 (es)
BR (1) BR112013030387A2 (es)
CA (1) CA2837162C (es)
CL (1) CL2013003387A1 (es)
CO (1) CO6862147A2 (es)
CR (1) CR20130618A (es)
CU (1) CU20130156A7 (es)
DO (1) DOP2013000278A (es)
EA (1) EA026550B1 (es)
EC (1) ECSP13013042A (es)
ES (1) ES2682247T3 (es)
GT (1) GT201300294A (es)
IL (1) IL228911A (es)
MA (1) MA35159B1 (es)
MX (1) MX362823B (es)
MY (1) MY186875A (es)
NZ (1) NZ616783A (es)
PE (1) PE20140580A1 (es)
PH (1) PH12013502446A1 (es)
SG (1) SG194544A1 (es)
TN (1) TN2013000492A1 (es)
TW (1) TWI551579B (es)
UA (1) UA113850C2 (es)
WO (1) WO2012163799A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013094546A1 (ja) * 2011-12-19 2015-04-27 住友化学株式会社 スルホン酸塩の製造方法
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101799B2 (en) 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
DE102005042742A1 (de) 2005-09-02 2007-03-08 Schering Ag Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
CA2622725A1 (en) * 2005-09-14 2007-03-22 Janssen Pharmaceutica N.V. 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
WO2007121269A2 (en) 2006-04-11 2007-10-25 Ardea Biosciences, Inc. N-aryl-n'alkyl sulfamides as mek inhibitors
ATE531720T1 (de) 2006-08-21 2011-11-15 Genentech Inc Aza-benzofuranylverbindungen und anwendungsverfahren dafür
EP1900739A1 (en) 2006-08-30 2008-03-19 Cellzome Ag Diazolodiazine derivatives as kinase inhibitors
CN103479604B (zh) * 2007-07-30 2016-08-10 阿迪生物科学公司 作为mek抑制剂的包括多晶型物的n-(芳氨基)磺酰胺衍生物和组合物、其使用方法和制备方法
CN102134218A (zh) 2009-06-15 2011-07-27 凯美隆(北京)药业技术有限公司 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

Also Published As

Publication number Publication date
KR101939682B1 (ko) 2019-01-17
SG194544A1 (en) 2013-12-30
US9328066B2 (en) 2016-05-03
EP2714652A1 (en) 2014-04-09
CL2013003387A1 (es) 2014-09-22
JP2014520087A (ja) 2014-08-21
TW201249791A (en) 2012-12-16
TN2013000492A1 (en) 2015-03-30
EA026550B1 (ru) 2017-04-28
EP2714652B8 (en) 2018-09-05
DOP2013000278A (es) 2013-12-31
GT201300294A (es) 2014-11-13
AR086553A1 (es) 2014-01-08
UA113850C2 (xx) 2017-03-27
CR20130618A (es) 2014-01-09
BR112013030387A2 (pt) 2016-12-13
MX2013013667A (es) 2014-08-01
IL228911A (en) 2017-10-31
IL228911A0 (en) 2013-12-31
CU20130156A7 (es) 2014-02-28
AP2013007257A0 (en) 2013-11-30
US20140155637A1 (en) 2014-06-05
WO2012163799A1 (en) 2012-12-06
CN103596921B (zh) 2016-08-03
MA35159B1 (fr) 2014-06-02
EA201301333A1 (ru) 2014-06-30
ECSP13013042A (es) 2014-01-31
AU2012264884B2 (en) 2017-03-09
ES2682247T3 (es) 2018-09-19
CA2837162C (en) 2019-04-02
PH12013502446A1 (en) 2014-01-20
CN103596921A (zh) 2014-02-19
NZ616783A (en) 2016-01-29
TWI551579B (zh) 2016-10-01
JP5965993B2 (ja) 2016-08-10
KR20140032433A (ko) 2014-03-14
CA2837162A1 (en) 2012-12-06
CO6862147A2 (es) 2014-02-10
MY186875A (en) 2021-08-26
AU2012264884A1 (en) 2013-11-07
EP2714652B1 (en) 2018-07-18
MX362823B (es) 2019-02-18

Similar Documents

Publication Publication Date Title
PE20120617A1 (es) Procesos para preparar cobicistat y sus productos intermedios
PH12012502352A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
NZ601805A (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
AR085155A1 (es) Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos
DOP2014000048A (es) Composiciones farmacéuticas que comprenden un polisacárido y un inhibidor hdac
DOP2011000362A (es) Metodo para la preparacion de hidrocloruro de nalmefeno activo
EA201290872A1 (ru) Способ получения бензоксаборолов
BR112015015097A2 (pt) método para produção de composto de amina purificada
AR084864A1 (es) Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
BR112014015962B8 (pt) Métodos para produzir 4-amino-3-cloro-6-(4-cloro-2-flúor-3-metóxi-fenil)piridina-2-carboxilato de metila
EA201200498A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
PE20140580A1 (es) Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropanosulfonamidas
MX2012001722A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
CL2012000739A1 (es) Procedimientos de preparacion del acido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotinico; y uno de los compuestos intermedios considerados.
MY160461A (en) Process for producing granules comprising one or more complexing agent salts
IN2015DN02241A (es)
EA201591487A1 (ru) Производные замещенной бисфенилбутановой кислоты в качестве ингибиторов nep с улучшенной in vivo эффективностью
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
EA201592167A1 (ru) Способ получения производных пирролидин-2-карбоновой кислоты
UA111329C2 (uk) Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою
UA118008C2 (uk) Спосіб синтезу (2е)-3-(3,4-диметоксифеніл)проп-2-еннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою
EA201300100A2 (ru) Способ ферментативного синтеза (7s)-3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбоновой кислоты или ее сложных эфиров и применение для синтеза ивабрадина и его соли
JO3276B1 (ar) طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا.
AR087118A1 (es) Metodo de preparacion de derivado de acido ciclohexano carboxilico

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed